FindTrial
Sign In

Metformin in women with cardiac syndrome X: a randomised double blind placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN28863939
Enrollment
Unknown
Registered
2002-01-31
Start date
1997-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac syndrome X Circulatory System

Interventions

1. Metformin 500 mg twice daily (BD) 2. Matching placebo 1 tab BD Both treatments will continue for 8 weeks.

Sponsors

British Heart Foundation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women, post menopausal but less than 70 years with Cardiac Syndrome X (definition angina/positive exercise test/normal coronary arteriogram)

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026